?? Meet AKASA Medical Coding: The first GenAI assistant for coders ?? Earlier this spring, we introduced you to Authorization Advisor, the first in a suite of generative AI (GenAI) revenue cycle assistants. Today, we’re building on that effort. ?? AKASA Medical Coding? is a new groundbreaking mid-cycle solution that puts the power of GenAI at medical coders’ fingertips, enabling them to work with unprecedented efficiency, accuracy, and comprehensiveness. The end result? More accurate coding, more efficient teams, and more appropriate revenue — all at a lower cost. Driven by our proprietary GenAI technology and trained on each health system’s clinical and financial data, AKASA Medical Coding: ?? Reads every relevant clinical document for every encounter (clinical notes, imaging reports, clinical observations, and more) ? Identifies recommended codes ?? Provides justifications (linked to supporting medical text) for coders to accept or revise ?? Shares AI confidence level indicators to make the approval process more efficient ?? Addresses multiple service lines, within the most complex inpatient settings ?? Combines clinical and EDI data to create a cohesive patient story Welcome to the next generation of medical coding technology. See AKASA Medical Coding in action: akasa.com/coding
关于我们
@Olive Capital
- 网站
-
https://www.olivevc.com/
Olive Capital的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 2-10 人
- 类型
- 合营企业